Genmab AS

Genmab AS P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Genmab AS (GMAB) as of Nov 22, 2026 is 12.97. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 1.98 — a change of 554.71% (higher).

P/CF

12.97

YoY

554.71%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Genmab AS is 2025 12.97 . P/CF (Price-to-Cash-Flow Ratio) of Genmab AS was 2024 1.98 . It decreases by 554.71% higher compared to the previous year.

The Genmab AS P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
15.17 USD
Jan 1, 2019
11.61 USD
Jan 1, 2020
2.39 USD
Jan 1, 2021
6.91 USD
Jan 1, 2022
3.94 USD
Jan 1, 2023
2.09 USD
Jan 1, 2024
1.98 USD
Jan 1, 2025
12.97 USD
The Genmab AS P/CF history
YEARP/CFYoY
12.97+554.71%
1.98-5.03%
2.09-46.99%
3.94-43.05%
6.91+188.73%
2.39-79.39%
11.61-23.47%
15.17+56.58%
9.69-79.38%
46.98-4.96%
49.44-57.40%
116.06—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab AS Stock analysis

What does Genmab AS do? Genmab AS is a biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. It develops and markets antibody-based therapies for cancer and other diseases, including EPKINLY, TEPKINLY, and Tivdak for various lymphomas and cervical cancer. The company also advances several product candidates in clinical development, such as Epcoritamab for lymphomas and GEN1059 for solid tumors, alongside established treatments like DARZALEX and TECVAYLI for multiple myeloma and other conditions. Genmab AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab AS stock

P/CF (Price-to-Cash-Flow Ratio) of Genmab AS is 12.97 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Genmab AS changed from 1.98 to 12.97, representing a 554.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Genmab AS since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Genmab AS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Genmab AS

All Key Metrics — Genmab AS